News

After a fourth quarter in which revenue boomed throughout the biopharma industry, there were reversals for several drugmakers ...
During his first term, Trump in 2020 had pushed a similar "most favored nation" rule for drug prices that would ... prescribed drugs such as Xarelto or Eliquis, which will take effect in 2026.
Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.
Generic and biosimilar drug producer Sandoz has agreed a $265 million settlement that aims to put allegations of price-fixing brought in a Pennsylvania lawsuit behind it. The agreement – which ...
chief executive of Switzerland’s Sandoz, said he backed the intention of the administration’s “most favoured nation” policy — where it is seeking to cut prescription drug prices to the ...
public comments and talks with drug companies before Medicare implemented discounts. The Biden administration lowered prices on 10 widely prescribed drugs, such as the blood thinner Eliquis ...
Lev Facher covers the U.S. addiction and overdose crisis. Drug deaths plummeted in 2024, according to new federal data. An estimated 80,391 people died of a drug overdose in the U.S. last year ...
Many women have, for decades, taken a drug called phenazopyridine to control pain from urinary tract infections. Sold under such brand names as Azo and Uristat, it’s available in most US ...
President Donald Trump signed an executive order on Monday aimed at slashing prescription drug prices in the U.S. that could lead to the capping of prices at a level equivalent to the cost in ...
(NEXSTAR) – The deadly and drug-resistant fungus Candida auris is under close surveillance as health experts work to calm its spread. Candida auris, also called C. auris, was first identified in ...
The big announcement that President Trump teased earlier this week in the Oval Office is a "most favored nation" plan to cut Medicare drug prices, sources told CBS News. The Trump administration ...